Status:
WITHDRAWN
Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Collaborating Sponsors:
HemoSonics LLC
Conditions:
Coagulopathy
Liver Transplantation
Eligibility:
All Genders
18-75 years
Brief Summary
Severe coagulopathy and operative bleeding are common in liver and multivisceral transplant recipients. This is related to reduced synthesis and function of clotting proteins in end-stage liver diseas...
Detailed Description
Blood clotting during surgery is a complex process affected by many factors, including low levels of clotting factors and/or platelets resulting from liver disease, varying levels of factors that prom...
Eligibility Criteria
Inclusion
- Sequential adult liver and multi visceral transplant recipients -
Exclusion
- None envisaged
- \-
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04274699
Start Date
October 1 2020
End Date
October 1 2021
Last Update
July 20 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.